Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
“M3 operates a medical-information platform for physicians, with an especially strong foothold in Japan. Pharmaceutical companies pay M3 to gain access to its physician network so they can market drugs. Over the years, the company has expanded beyond its core offering to include services such as clinical-trial support and patient engagement, building an ecosystem that is unrivaled in the country and difficult to replace. While some investors fear pharmaceutical companies will use AI to bring those activities in-house, they lack the breadth of physician behavioral data that M3 has accumulated. The company is already using AI to better serve its users. What drives traffic and engagement on the platform is not general internet searches but rather physicians visiting the site directly, often daily, to access personalized content. Roughly 80% of the platform's landing page is customized for each physician using AI, and the time physicians spend on the platform has actually increased 24% since AI chatbots such as ChatGPT were introduced. As of now, management estimates that services potentially vulnerable to AI substitution account for only about 1% of revenue. It appears more likely that AI will strengthen M3's competitive position by helping it collect and analyze data more effectively to improve personalization and develop new services for physicians, patients, and drugmakers.” | NEUTRAL | Q2 2026 Jul 28, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
